The General Administration of Supervision of the China Market emphasized that the price trend of the price -related materials such as drugs will be closely concerned, and the market supervision departments in various places will severely crack down on illegal acts such as hoarding and raising prices.

According to the First Financial report, the Chinese Market Supervision Administration has concentrated on the price of the price of some drugs such as some drugs such as some drugs such as the fluctuation of the price fluctuations in the price of some drugs.Relevant provinces market supervision departments are investigated and dealt with.

The General Administration of Supervision of the China Market said, the verification found that when the purchase cost was not much changed, some operators began to increase the sales price in early December.For example, a certain online pharmacy sells the flowers of the flowers of the flowers 6g*10 bags/box, and the purchase price is 23.5 to 32 yuan/box (RMB, the same below, the same, S $ 4.21/box), the sales price is 26.8 to 38 yuan/Boxes, but rose rapidly from early December, rising to 99 yuan/box on December 5.

The General Administration of Supervision pointed out that the above pharmacies have greatly increased sales prices without significantly increased costs, or their costs have increased significantly higher than the cost growth rate, which has suspected of constituting the price of coaxing.

In response to the fluctuations and market competition issues such as some drugs such as some drugs and other drugs, the General Administration of Market Supervision issued the warning of the reminder of the price and competition order of the immune -related materials, from the aspects of standardized price behavior, maintaining fair competition, etc.The production operators of the epidemic materials have scratched the "nine unbearable" red line.

Reminder the warning of the warning clearly requires production and operators not to violate the principles of honesty and fairness and fairness, must not violate the specifications of the price price, must not raise prices, must not be scammed, do not string up price increases, no price discrimination, must not be false, must not be falsePropaganda, no fascination, and no business slander.